spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, J. F.
Right arrow Articles by Hart, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, J. F.
Right arrow Articles by Hart, I. R.

Journal of Cell Science, Vol 108, Issue 3 1227-1238, Copyright © 1995 by Company of Biologists


JOURNAL ARTICLES

Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin

JF Marshall, DC Rutherford, AC McCartney, F Mitjans, SL Goodman and IR Hart
Richard Dimbleby Department of Cancer Research/ICRF Laboratory, St Thomas' Hospital, London, UK.

We have shown previously that VUP was the only line out of ten human melanoma lines that failed to express the vitronectin receptor alpha v beta 3, but instead expressed alpha v beta 1. Levels of alpha v beta 1 expression were low on parental VUP cells so that iterative sorting by FACS, using an anti-alpha v antibody (13C2), was utilised to derive sublines with 8- to 10-fold higher amounts of cell surface alpha v beta 1. There was little difference between low (V-) and high (V+) alpha v beta 1-expressing sublines with regard to adherence to collagen type I, collagen type IV or laminin substrata. However, adherence to vitronectin and fibrinogen correlated closely with alpha v beta 1 expression (35-42% adhesion for V(+) lines versus 6-8% adhesion for V- lines on vitronectin, for example). Utilising a high alpha v beta 1-expressing subline (V + B2) we have shown that binding to vitronectin and fibrinogen was inhibited specifically by function-blocking antibodies to alpha v (17E6 and 14D9) and beta 1 (A11B2). V(+) sublines spread more compared with V(-) sublines on both vitronectin and fibronectin. However, neither alpha 5- nor alpha v-blocking antibodies had any effect on attachment or spreading of V + B2 on fibronectin whereas the combination of alpha 5 (PID6)- and alpha v(17E6)-blocking antibodies abrogated binding to fibronectin almost completely. This is the first report of an alpha v beta 1 integrin able to recognize vitronectin and fibrinogen, and also cooperate with alpha 5 beta 1 to mediate attachment to and spreading on fibronectin.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Kaido, B. Perez, M. Yebra, J. Hill, V. Cirulli, A. Hayek, and A. M. Montgomery
{alpha}v-Integrin Utilization in Human {beta}-Cell Adhesion, Spreading, and Motility
J. Biol. Chem., April 23, 2004; 279(17): 17731 - 17737.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. M. Beattie, A. M.P. Montgomery, A. D. Lopez, E. Hao, B. Perez, M. L. Just, J. R.T. Lakey, M. E. Hart, and A. Hayek
A Novel Approach to Increase Human Islet Cell Mass While Preserving {beta}-Cell Function
Diabetes, December 1, 2002; 51(12): 3435 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Pilch, R. Habermann, and B. Felding-Habermann
Unique Ability of Integrin alpha vbeta 3 to Support Tumor Cell Arrest under Dynamic Flow Conditions
J. Biol. Chem., June 7, 2002; 277(24): 21930 - 21938.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Jackson, A. P. Mould, D. Sheppard, and A. M. Q. King
Integrin {alpha}v{beta}1 Is a Receptor for Foot-and-Mouth Disease Virus
J. Virol., February 1, 2002; 76(3): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Li, S. L. Brown, D. G. Stupack, X. S. Puente, D. A. Cheresh, and G. R. Nemerow
Integrin {alpha}v{beta}1 Is an Adenovirus Coreceptor
J. Virol., June 1, 2001; 75(11): 5405 - 5409.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
K. O Yee, M. M. Rooney, C. M. Giachelli, S. T. Lord, and S. M. Schwartz
Role of ß1 and ß3 Integrins in Human Smooth Muscle Cell Adhesion to and Contraction of Fibrin Clots In Vitro
Circ. Res., August 10, 1998; 83(3): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. Felding-Habermann, S. Silletti, F. Mei, C.-H. Siu, P. M. Yip, P. C. Brooks, D. A. Cheresh, T. E. O'Toole, M. H. Ginsberg, and A. M.P. Montgomery
A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins
J. Cell Biol., December 15, 1997; 139(6): 1567 - 1581.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F Mitjans, D Sander, J Adan, A Sutter, J. Martinez, C. Jaggle, J. Moyano, H. Kreysch, J Piulats, and S. Goodman
An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice
J. Cell Sci., January 8, 1995; 108(8): 2825 - 2838.
[Abstract] [PDF]




© The Company of Biologists Ltd 1995